-
Mashup Score: 1Software assembles complete genome sequences on-demand - 1 year(s) ago
National Institutes of Health (NIH) researchers have released an innovative software tool that makes assembling complete genome sequences from a variety of species more affordable and accessible. The study, published February 16 in Nature Biotechnology, describes the software, called Verkko — “network” in Finnish.
Source: Scienceboard.netCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1Protein makes melanoma more aggressive - 1 year(s) ago
Queen Mary University of London, King’s College London, and Francis Crick Institute Research scientists have identified a protein that makes melanoma more aggressive. The study, published January 9 in the journal Nature Cell Biology, contributes to the understanding of melanoma progression, and may facilitate new ways to target melanoma, the most serious form of skin cancer.
Source: Scienceboard.netCategories: Hem/Oncs, Latest HeadlinesTweet-
Interesting model that examines the physical act of #metastasis in vitro by #melanoma cells, ultimately identifying a protein that may facilitate #cancer spread, and could be a useful treatment target: https://t.co/hm9ClKXH58
-
-
Mashup Score: 0Certain protein creates domino effect to set off ALS - 1 year(s) ago
King’s College London researchers have found that the loss of a processing protein is likely the molecular trigger in the neurodegenerative disorder amyotrophic lateral sclerosis (ALS).
Source: Scienceboard.netCategories: Latest Headlines, Rare DiseaseTweet-
Certain protein creates domino effect to set off ALS via @ScienceBoard https://t.co/YGfVKdfkt3
-
-
Mashup Score: 6
Massachusetts General Hospital researchers have engineered a CRISPR-Cas9 variant that overcomes a previous restriction on the locations that DNA can be cut in the laboratory, suggesting molecular cloning approaches can be simplified.
Source: Scienceboard.netCategories: Future of Medicine, Latest HeadlinesTweet-
CRISPR-Cas9 variant enables DNA cutting at ‘practically any sequence’ #NBTintheNews via @ScienceBoard https://t.co/cTS5aKNwDx
-
-
Mashup Score: 0
The U.S. Food and Drug Administration (FDA) has elevated and reorganized its Office of Tissues and Advanced Therapies to a “Super Office” within the Center of Biologics Research and Evaluation to meet its growing cell and gene therapy workload.
Source: Scienceboard.netCategories: Hem/Oncs, Latest HeadlinesTweet-
FDA creates “Super Office” to manage growing cell and gene therapy workload via @ScienceBoard https://t.co/eRtdIKrRPi
-
-
Mashup Score: 0Gene therapy shows promise in treating ALS in rodent models - 2 year(s) ago
A gene therapy, patented through the University of California, San Diego and the Department of Veterans Affairs, and licensed to Eikonoklastes Therapeutics, measurably delayed disease onset in humanized mouse and rat models of familial amyotrophic lateral sclerosis (ALS).
Source: Scienceboard.netCategories: Latest Headlines, Rare DiseaseTweet-
Lucky rodents... Gene therapy shows promise in treating ALS in rodent models via @ScienceBoard https://t.co/wmEWPThzPG
-
-
Mashup Score: 5
Researchers have used imaging and transcriptomics to identify T cells with potent serial killing capacity in a push to expand use of the immunotherapies to solid tumors.
Source: Scienceboard.netCategories: Future of Medicine, Latest HeadlinesTweet-
@Dream3DLab @IamAnneRios @prinsesmaximac @oncodeinstitute @TheCleversLab @JKuball @ZsoltSebestyen2 3D imaging reveals picture of T-cell activity to unlock solid tumor opportunity #NBTintheNews via @ScienceBoard https://t.co/iQsmUUFv1r
-
-
Mashup Score: 0
A genetic discovery by a University of Exeter research team supports the theory that degenerative motor neuron diseases (MNDs) are caused by abnormal lipid processing pathways inside braincells, which could help pave the way for new diagnostic approaches and treatments for this group of conditions.
Source: Scienceboard.netCategories: Latest Headlines, Rare DiseaseTweet-
https://t.co/zehiRAkRDi
-
-
Mashup Score: 7MASTER technology could transform CAR T-cell therapy - 2 year(s) ago
A new technology that helps CAR T cells attack cancer cells more aggressively than conventional methods has been published by researchers from North Carolina. Called multifunctional alginate scaffold for T-cell engineering and release (MASTER), the technology was described in a paper published on March 24 in Nature Biotechnology.
Source: Scienceboard.netCategories: Future of Medicine, Latest HeadlinesTweet-
@ncbiotech @WRALTechWire MASTER technology could transform CAR T-cell therapy #NBTintheNews via @ScienceBoard https://t.co/N8pcFLYFuA https://t.co/B2cBwVpmlZ
-
-
Mashup Score: 6Bacteria don invisibility cloak to fight cancer - 2 year(s) ago
Using bacteria to target tumors is a promising avenue for developing new treatments, although the risk of severe side effects is holding back clinical trials. Now, in a new study published on March 17 in Nature Biotechnology, researchers have developed a way to reversibly hide the microbes from the immune system, providing control over their growth.
Source: Scienceboard.netCategories: Future of Medicine, Latest HeadlinesTweet-
@FierceBiotech Bacteria don invisibility cloak to fight cancer #NBTintheNews via @ScienceBoard https://t.co/1QuWhPHxp1
-
@genome_gov @uwgenome @HHMINEWS @sergekoren @MikkoRautiaine3 @NIH Software assembles complete genome sequences on-demand #NBTintheNews via @ScienceBoard https://t.co/oAuA9zzyhD